Pancreatic Cancer Research

ResearcherSapporo Medical UniversityActive in the last 2 years

Makoto Yoshida

Matched on ORCID iD 0000-0001-8013-9712; OpenAlex author ID A5101507560. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy: A retrospective multice… Co-author DOI 10.21203/rs.3.rs-9156519/v1↗
  2. Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report. First author DOI 10.2169/internalmedicine.6765-25↗
  3. Role of preoperative circulating tumor DNA in predicting occult metastases in resectable and borderline resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.3748/wjg.v31.i32.109383↗
  4. Predictors of occult metastases in potentially Resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.sopen.2024.07.010↗
  5. Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Co-author DOI 10.1093/jjco/hyad131↗
  6. Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancre… Co-author DOI 10.1002/jhbp.1353↗
  7. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable … Co-author DOI 10.1136/bmjopen-2020-045698↗
  8. Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review. First author DOI 10.1007/s13691-020-00405-7↗
  9. Non-negligible rate of needle tract seeding after endoscopic ultrasound-guided fine-needle aspiration for patients undergoing distal pancreatectomy for pancrea… Co-author DOI 10.1111/den.13615↗
  10. Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter… Co-author DOI 10.1002/ags3.12272↗
  11. Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderl… Co-author DOI 10.1016/j.ijrobp.2019.07.004↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohichi Takada · 4 shared papers, 2020–2026 · strength 0.86
  2. Masafumi Imamura · 4 shared papers, 2019–2026 · strength 0.75
  3. Yasutoshi Kimura · 4 shared papers, 2019–2025 · strength 0.57
  4. Tomohiro Kubo · 3 shared papers, 2020–2025 · strength 0.50
  5. Ichiro Takemasa · 3 shared papers, 2019–2025 · strength 0.49
  6. Joji Muramatsu · 2 shared papers, 2024–2026 · strength 0.44
  7. Takeshi Murakami · 2 shared papers, 2024–2025 · strength 0.41
  8. Masayo Motoya · 3 shared papers, 2019–2025 · strength 0.36
  9. Satoshi Hirano · 3 shared papers, 2019–2023 · strength 0.30
  10. Akari Goto · 1 shared paper, 2026 · strength 0.30
  11. Masayoshi Kobune · 1 shared paper, 2026 · strength 0.30
  12. Yuki Ikeda · 2 shared papers, 2020–2024 · strength 0.29
  13. Masaki Kuwatani · 3 shared papers, 2019–2021 · strength 0.28
  14. Akio Katanuma · 3 shared papers, 2019–2021 · strength 0.28
  15. Hiroshi Nakase · 1 shared paper, 2024 · strength 0.21
  16. Tõru Nakamura · 1 shared paper, 2025 · strength 0.20
  17. Siew‐Kee Low · 1 shared paper, 2025 · strength 0.20
  18. Kazunori Watanabe · 1 shared paper, 2025 · strength 0.20
  19. Daisuke Kyuno · 1 shared paper, 2025 · strength 0.20
  20. Makoto Usami · 1 shared paper, 2024 · strength 0.17
  21. Tsuyoshi Hayashi · 2 shared papers, 2019 · strength 0.15
  22. Toru Nakamura · 2 shared papers, 2019 · strength 0.15
  23. Akira Fukutomi · 1 shared paper, 2023 · strength 0.15
  24. Sohei Satoi · 1 shared paper, 2023 · strength 0.15
  25. Teiichi Sugiura · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.